Hong Kong · Delayed Price · Currency is HKD Jinhai Medical Technology Statistics
Total Valuation
HKG:2225 has a market cap or net worth of HKD 24.32 billion. The enterprise value is 24.22 billion.
| Market Cap | 24.32B |
| Enterprise Value | 24.22B |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2225 has 5.30 billion shares outstanding. The number of shares has increased by 2.07% in one year.
| Current Share Class | 5.30B |
| Shares Outstanding | 5.30B |
| Shares Change (YoY) | +2.07% |
| Shares Change (QoQ) | +0.59% |
| Owned by Insiders (%) | 48.50% |
| Owned by Institutions (%) | 0.11% |
| Float | 2.73B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 61.03 |
| PB Ratio | 72.03 |
| P/TBV Ratio | 78.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 60.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.72 |
| Quick Ratio | 1.44 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.82 |
| Interest Coverage | -19.96 |
Financial Efficiency
Return on equity (ROE) is -24.49% and return on invested capital (ROIC) is -30.97%.
| Return on Equity (ROE) | -24.49% |
| Return on Assets (ROA) | -9.10% |
| Return on Invested Capital (ROIC) | -30.97% |
| Return on Capital Employed (ROCE) | -19.18% |
| Weighted Average Cost of Capital (WACC) | 6.48% |
| Revenue Per Employee | 844,385 |
| Profits Per Employee | -143,654 |
| Employee Count | 472 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 18.34 |
Taxes
In the past 12 months, HKG:2225 has paid 4.78 million in taxes.
| Income Tax | 4.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +341.35% in the last 52 weeks. The beta is 0.41, so HKG:2225's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +341.35% |
| 50-Day Moving Average | 5.10 |
| 200-Day Moving Average | 3.32 |
| Relative Strength Index (RSI) | 42.56 |
| Average Volume (20 Days) | 8,156,117 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2225 had revenue of HKD 398.55 million and -67.80 million in losses. Loss per share was -0.01.
| Revenue | 398.55M |
| Gross Profit | 71.08M |
| Operating Income | -66.40M |
| Pretax Income | -57.19M |
| Net Income | -67.80M |
| EBITDA | -43.28M |
| EBIT | -66.40M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 209.41 million in cash and 86.13 million in debt, with a net cash position of 123.28 million or 0.02 per share.
| Cash & Cash Equivalents | 209.41M |
| Total Debt | 86.13M |
| Net Cash | 123.28M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 337.65M |
| Book Value Per Share | 0.06 |
| Working Capital | 187.82M |
Cash Flow
In the last 12 months, operating cash flow was -29.57 million and capital expenditures -17.73 million, giving a free cash flow of -47.30 million.
| Operating Cash Flow | -29.57M |
| Capital Expenditures | -17.73M |
| Depreciation & Amortization | 23.38M |
| Net Borrowing | -1.56M |
| Free Cash Flow | -47.30M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 17.83%, with operating and profit margins of -16.66% and -17.01%.
| Gross Margin | 17.83% |
| Operating Margin | -16.66% |
| Pretax Margin | -14.35% |
| Profit Margin | -17.01% |
| EBITDA Margin | -10.86% |
| EBIT Margin | -16.66% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2225 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.07% |
| Shareholder Yield | -2.07% |
| Earnings Yield | -0.28% |
| FCF Yield | -0.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 12, 2024. It was a forward split with a ratio of 4.
| Last Split Date | Dec 12, 2024 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
HKG:2225 has an Altman Z-Score of 22.78 and a Piotroski F-Score of 4.
| Altman Z-Score | 22.78 |
| Piotroski F-Score | 4 |